アルマック・ファーマシューティカル・サービス株式会社
- HOME
- アルマック・ファーマシューティカル・サービス株式会社
- 製品・サービス詳細
- 超低温ラベリング・包装および配送 Ultra-Low Temperature Packaging & Distribution Solutions
医薬化合物の受託合成 CDMO
会社カテゴリー:原薬・添加剤・中間体、製造受託機関(CMO)、分析、試験受託サービス、医薬品製造、化成品製造
主サービス提供地域:日本、アメリカ合衆国、大韓民国、台湾、ヨーロッパ(イギリス以外)、イギリス
製品・サービス詳細
超低温ラベリング・包装および配送 Ultra-Low Temperature Packaging & Distribution Solutions
サービスカテゴリー:包装
Ultra-Low Temperature Packaging & Distribution Solutions
With more than 50 years’ experience, we offer a wide range of specialised packaging solutions to meet, and deliver your product launch and ongoing commercial needs. Almac Pharma Services was one of the first European CDMOs to support Gene Therapy product launches and currently provides solutions for over 25% of EU approved/ pre-registration ATMPs having processed and QP released over 600 batches to date. Our specialist team offers a wealth of expert knowledge, deep understanding, and a partnership enabling the processing and release of your tailored treatment, on time.
We specialise in providing unique, tailored solutions supporting your Advanced Therapy Medicinal Product (ATMP) and other specialist product launches through Justin-Time labelling, packaging, and serialisation at ultra-low temperatures (-20°C to -80°C) offering clients a uniquely tailored experience ensuring every step of the highly complex process is adjusted to meet your specific requirements. Our bespoke offering enables your life saving ATMP to be processed and released to patients exactly when needed within as little as 20 hours. Offering a flexible range of solutions, we partner with each client to define and agree a tailored, robust and commercially scalable process that meets your needs, taking into consideration:
• Temperature requirements (-20°C to -80°C)
• Allowable time out of condition (ambient/dry ice packaging)
• Conditioning time requirements
• Final pack-out configuration (inc. ancillary components)
• Level of serialisation aggregation required
• Temperature controlled distribution and global supplyc hain
Our dedicated team of fully qualified and licenced QPs is on hand to provide expert advice offering a personalised end-toend consultancy service to guide you through the challenging landscape of specialist product launch.
Almac’s expertise in temperature-controlled logistics, combined with our long established relationships with reputable, experienced, and trusted supply chain providers, offers you a comprehensive end-to-end service. This guarantees expedited delivery of your product direct to patient. Our use of innovative shippers, temperature monitors, and digital platforms which enables real-time visibility into product and shipper conditions, as well as location of the shipment, ensures your valuable Gene Therapy will not be compromised during transit. Through our work with a variety of ATMPs, we recognise there is little commonality, and each is distinctive in its requirements to guarantee product integrity throughout the entire process. We understand the specific needs of each product, and with our unique experience and tailored offering, we can identify and work within the individual constraints. Such as, managing the time spent out of temperature and the affects this can have on the efficacy of the drug product, or having a weightbased Gene Therapy product which requires country-specific packaging, complete with patient specific information on each pack, and to be distributed accordingly. Tailored Treatment. Delivered through: • Hand-in-hand consultancy • Risk mitigation • Proven track record Almac is proud to be a trusted partner with our clients in being able to ensure your tailored treatment is delivered. |
|